NATR

Business Context and Reporting Period

Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2001
Business Overview: The Company manufactures and distributes nutritional supplements through an independent sales force of Managers and Distributors. Operations are segmented geographically into the United States, Latin America, Asia Pacific, and Other markets.

Key Financial Metrics

Margins (9 Months 2001):
- Gross Margin (Sales less COGS): ~82.0%
- Operating Margin: ~8.2%
- Net Profit Margin: ~5.4%

Material Changes vs. Prior Period

• Sales Growth: Sales increased 1.0% for the quarter and 1.3% for the nine months compared to the prior year. Growth was driven by international operations (excluding Latin America) and U.S. operations in the quarter.
• Profitability Decline: Net income decreased 5.7% for the quarter and 6.7% for the nine months. Operating income declined 10.4% (quarter) and 10.1% (nine months) due to increased expenses.
• Segment Performance:
  • Latin America: Sales decreased 13.6% (quarter) and 5.2% (nine months), primarily due to Brazilian government import restrictions on nutritional supplements.
  • Asia Pacific: Sales increased 20.2% (quarter) and 16.1% (nine months), driven by growth in South Korea and the Synergy Japan acquisition.
  • Other Markets: Sales increased 26.3% (quarter) and 22.7% (nine months), led by operations in Russia and Israel.
• Expense Increases: Selling, general, and administrative (SG&A) expenses increased as a percentage of sales, largely due to integration costs associated with the Synergy Japan acquisition. Cost of goods sold increased slightly as a percentage of sales due to currency devaluations and higher international COGS.
• Cash Flow: Cash and cash equivalents decreased by $2.4 million over the nine months. This was primarily due to capital expenditures of $13.2 million for manufacturing facility expansion and increased inventory levels.

Guidance, Outlook, and Risks

• Outlook: Management expects cost of goods sold to remain relatively constant as a percent of sales for the remainder of 2001. Volume incentives and SG&A expenses are expected to decrease slightly as a percent of sales due to increased sales volume and expense controls.
• Capital Projects: The Company is expanding its manufacturing facility with a total expected cost of $14.0 million; $11.6 million had been paid as of September 30, 2001. Completion is scheduled for the second quarter of 2002. Funding is expected to come from working capital.
• Liquidity: The Company has no short-term debt and no credit facility. Management believes internal funds are sufficient for foreseeable needs, though a prolonged economic downturn could impact long-term liquidity.
• Risks:
  • Foreign Currency: Approximately 44% of revenue is realized outside the U.S. A strengthening U.S. dollar negatively impacts sales and expenses. The Company does not use derivative instruments for hedging.
  • Regulatory: Continued negative impact expected from Brazilian import restrictions.
  • Legal: The Company is a defendant in various incidental lawsuits, which management does not expect to have a material effect.

Investor Verification Checklist

• Verify the extent of the impact of Brazilian import regulations on future Latin American sales.
• Confirm the timeline and remaining capital requirements for the manufacturing facility expansion.
• Monitor the integration progress and cost synergies of the Synergy Japan acquisition.
• Assess the sensitivity of operating margins to further fluctuations in foreign exchange rates, particularly in Brazil, Japan, and South Korea.
• Review the trend in the number of active Managers and Distributors to gauge sales force stability.